-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Akero Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2022 to 2023.
- Akero Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2024 was $1.25M, a 40.3% increase year-over-year.
- Akero Therapeutics, Inc. Interest Expense for the twelve months ending September 30, 2024 was $4.37M.
- Akero Therapeutics, Inc. annual Interest Expense for 2023 was $3.1M, a 319% increase from 2022.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)